BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Amarin

About Amarin

Amarin is a biotechnology neuroscience company focused on developing novel drugs for the treatment of central nervous system disorders. Amarinís leading pipeline product, MiraxionTM, is in development for a number of therapeutic indications including Huntingtonís disease ("HD") and treatment-unresponsive depression. Amarin is listed on the Nasdaq small cap market (ticker: AMRN), has headquarters in London and a research and development facility in Stirling, Scotland.

 

PRODUCTS IN DEVELOPMENT

 

Miraxion for Huntington's Disease and unrepsonsive depression

 

 

More on Amarin

Home Page

Key Statistics for Amarin

Basic Chart for Amarin

Analyst Opinion

Analysts Estimates

News

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com